000			02352 a2200637 4500
005			20250517025227.0
264		0	_c20160105
008			201601s 0 0 eng d
022			_a1815-7920
024	7		_a10.5588/ijtld.14.0535 _2doi
040			_aNLM _beng _cNLM
100	1		_aKuaban, C
245	0	0	_aHigh effectiveness of a 12-month regimen for MDR-TB patients in Cameroon. _h[electronic resource]
260			_bThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease _cMay 2015
300			_a517-24 p. _bdigital
500			_aPublication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntitubercular Agents _xadverse effects
650	0	4	_aCameroon
650	0	4	_aClofazimine _xtherapeutic use
650	0	4	_aCohort Studies
650	0	4	_aConfidence Intervals
650	0	4	_aDeveloping Countries
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Therapy, Combination
650	0	4	_aDrug-Related Side Effects and Adverse Reactions _xepidemiology
650	0	4	_aEthambutol _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aFluoroquinolones _xtherapeutic use
650	0	4	_aGatifloxacin
650	0	4	_aHumans
650	0	4	_aIsoniazid _xtherapeutic use
650	0	4	_aKanamycin _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOdds Ratio
650	0	4	_aProspective Studies
650	0	4	_aProthionamide _xtherapeutic use
650	0	4	_aPyrazinamide _xtherapeutic use
650	0	4	_aRisk Assessment
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aTuberculosis, Multidrug-Resistant _xdiagnosis
650	0	4	_aYoung Adult
650	0	4	_aAssessment of Medication Adherence
700	1		_aNoeske, J
700	1		_aRieder, H L
700	1		_aAït-Khaled, N
700	1		_aAbena Foe, J L
700	1		_aTrébucq, A
773	0		_tThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease _gvol. 19 _gno. 5 _gp. 517-24
856	4	0	_uhttps://doi.org/10.5588/ijtld.14.0535 _zAvailable from publisher's website
999			_c24798961 _d24798961